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Abstract 
Diabetes mellitus is a worldwide highly prevalent chronic metabolic disorder, characterized by 
hyperglycemia, and is associated with significant complications, including the microvascular 
complications such as neuropathy, retinopathy and nephropathy and the macrovascular complications 
such as cardiovascular, cerebrovascular disease and peripheral vascular disease, thus leading to 
significant morbidity and mortality. Patients with diabetes were found to be 1.4-3 times more likely to 
suffer from comorbid depression when compared to non-diabetics, and depression in diabetes is usually 
persistent and/or recurrent. Depression was found to be increased among patients with type I and type II 
diabetes mellitus, which have higher glycosylated hemoglobin. Association was also found between 
diabetic complications and depression, and this relation is bidirectional since depression might be linked 
to poor glycemic control and complications lead to negative impact on patients’ physical and mental 
health and leads to worse quality of life, thus fostering the development of depression. The presence of 
depression by itself was found to be associated with significant negative impact in their diabetes self-
care and having proper glycemic control, and led to worse health outcomes and quality of life. Thus, 
American Diabetes Association currently recommends that patients with diabetes mellitus, especially 
those with poor glycemic control, should be screened for depression. 
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ABSTRACT  
Diabetes mellitus is a worldwide highly prevalent chronic metabolic disorder, characterized by 
hyperglycemia, and is associated with significant complications, including the microvascular 
complications such as neuropathy, retinopathy and nephropathy and the macrovascular complications 
such as cardiovascular, cerebrovascular disease and peripheral vascular disease, thus leading to 
significant morbidity and mortality. Patients with diabetes were found to be 1.4-3 times more likely to 
suffer from comorbid depression when compared to non-diabetics, and depression in diabetes is usually 
persistent and/or recurrent. Depression was found to be increased among patients with type I and type II 
diabetes mellitus, which have higher glycosylated hemoglobin. Association was also found between 
diabetic complications and depression, and this relation is bidirectional since depression might be linked 
to poor glycemic control and complications lead to negative impact on patients’ physical and mental health 
and leads to worse quality of life, thus fostering the development of depression. The presence of depression 
by itself was found to be associated with significant negative impact in their diabetes self-care and having 
proper glycemic control, and led to worse health outcomes and quality of life. Thus, American Diabetes 
Association currently recommends that patients with diabetes mellitus, especially those with poor glycemic 
control, should be screened for depression. 
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1. INTRODUCTION 
Diabetes mellitus (DM), which is a major public health concern, is known to be increasing 
worldwide, where the estimated number of patients with diabetes was 382 million in 2013; and this 
number is further expected to increase to 592 million by the year 2035 (American Diabetes Association, 
2013). Diabetes mellitus is a chronic disease, characterized by hyperglycemia, resulting from 
impairment in insulin secretion, or defects in insulin action, or combination of both. Diabetes is further 
categorized into three major types: Type 1 diabetes mellitus (T1D), characterized by insulin deficiency, 
secondary to autoimmune destruction of insulin-producing pancreatic B cells (Gorsuch, 1981, Knip, 
2008), Type 2 DM (T2D), characterized by resistance to insulin action, and incapability of Beta cells to 
secrete sufficient amounts of insulin (Scheen 2003), and Gestational diabetes (GDM), also known as 
diabetes of pregnancy, caused partly by the hormones which are released from the placenta and partly 
by obesity and other pregnancy related factors that are not fully understood (Kampmann 2015). 
Depression is also one of the chronic, commonly diagnosed mental disorders, among adults, that leads 
to significant personal and interpersonal suffering along with its societal impact, and thus is considered 
to be a major public health concern (Johnson, 1992). As described in the Diagnostic and Statistical 
Manual of Mental  Disorders, 5th edition (DSM- V), major depressive disorder (MDD) is the presence 
of depressed mood (dysphoria) along with loss of interest in activities that used to be pleasurable in the 
past  (anhedonia) for at least two weeks duration. These are usually accompanied by at least four of the 
following manifestations, such as, changes in sleep patterns, appetite or weight, altered psychomotor  
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activity, feelings of worthlessness or guilt, difficulty in concentration or  making decisions, and 
recurrent thoughts of death or suicidal ideation (American Psychiatric Association 2013). There are 
different theories trying to explain the pathophysiology of depression. Different structural and 
functional studies have shown that there are abnormalities in the brain areas which are normally 
responsible for mood regulation, reward response and executive functions in patients with depression. 
In addition, chronic stress and the increased activity of the hypothalamic pituitary adrenal axis results 
in high cortisol levels and this has been hypothesized to also play an important  role in the incidence of 
depression and the recurrence of depression even after its complete remission. Genetic factors also play 
a role despite the fact that no single gene polymorphism was identified but genetic factors do make a 
person predisposed to depression under stressful environmental factors. In addition, dysfunction in the 
serotonergic system was found to be implicated in mood and anxiety disorders. Furthermore, group of 
patients have been reported to have low levels of 5-hydroxyindoleacetic acid (5-HIAA) a metabolite of 
5-Hydroxy-Tryptophane in the cerebrospinal fluid (CSF), and this has been linked to aggressive 
behavior and increased suicidal intent and impulsivity. Recently, it was mentioned that depression is an 
inflammatory disorder, since many pro-inflammatory marker levels were found to be elevated in 
depressed patients. Moreover, significant atrophy was observed in certain prefrontal cortical areas and 
hippocampal area (Fekadu, 2017). 
Although the prevalence of mental disorders, in general, in patients with diabetes mellitus is found 
to be comparable to that of the general population, but an increased prevalence of depressive disorders, 
have been reported in patients with diabetes mellitus. The aim of this review is to highlight briefly the 
relationship between depression and diabetes and its relation to glycemic control. In addition, 
relationship between diabetes complications and depression is highlighted. 
 
2. DEPRESSION AND DIABETES 
In a meta-analyses conducted, including 42 studies, with a total of 20,218 subjects, it was found that 
diabetes and depression were found to occur together approximately twice as frequently as would be 
predicted by chance alone, and the odds of depression, in the diabetic group, were twice that of the non-
diabetic group  (Anderson 2001). It was also found that the prevalence of co-morbid depression was 
significantly higher in diabetic women (28%) when compared to diabetic men (18%) (Anderson 2001). 
Another recent meta-analysis including 11 studies, and nearly 50,000 people, who had type 2 diabetes, 
without depression at baseline, showed that the incidence of depression is 24 % higher in those people 
with diabetes mellitus (Nouwen¸2010).  Furthermore, it was found that the combination of diabetes and 
depression worsened the outcomes of each other, as patients with diabetes, who are depressed, are 
known to have a worse quality of life, impaired diabetes self-management and reduced life expectancy 
(Holt, 2012). In children and adolescents, few studies are conducted, about the association of diabetes 
and depression. However, one of the studies done in children and adolescents suggested that the rates 
of depression are increased in either type 1 or type 2 diabetes with an overall prevalence rates ranging 
from 9 –26 % (Reynolds, 2011). Thus, epidemiologic studies have consistently demonstrated that there 
is an association between depression and diabetes and this association is bi-directional (Mezuk 2008, 
Golden, 2008). An 8-year follow-up study was carried out in Japan, on 2,764 patients, and it was found 
that patients with moderate to severe depressive symptoms had over 2-fold higher risk of diabetes 
compared to those who had no depression (Kawakami, 1999). 
 
3. PATHOGENESIS UNDERLYING ASSOCIATION BETWEEN DIABETES AND 
DEPRESSION 
Many theoretical models were proposed trying to explain the co-morbidity of diabetes and depression and 
their bi-directional relationship. Depression is known to result in individuals suffering from a demanding stressful 
chronic physical illness such as diabetes mellitus. Knowledge of the diagnoses of diabetes, its complications and 
the burden of managing the condition were associated with increased rates of depression, thus suggesting that 
healthcare professionals may actually play a role in moderating the psychological burden that is often associated 
with diabetes diagnosis (Holt, 2014). It is also likely that antidepressants use contributes to diabetes risk, where 
some case reports and observational studies have shown that there is association between antidepressant 
medications use and diabetes risk but this relationship was not proved (Barnard, 2013, Bhattacharjee, 2013). 
Furthermore, hypoglycemia and hyperglycemia may have major effects on brain function, where magnetic 
resonance imaging (MRI) scanning of brains of people with type 1 diabetes, revealed that the prefrontal glutamate-
glutamine-gamma-aminobutyric acid levels were actually elevated and these levels usually correlate with mild 
depressive symptoms (Lyoo, 2009). In addition, it is known that both depression and diabetes are associated with 
dysfunction of the hypothalamic-pituitary adrenal (HPA) axis, leading to subclinical hypercortisolism and a 
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blunted diurnal cortisol rhythm with associated increase in inflammation (Champaneri 2010). Another theory 
proposed that disrupted sleep patterns which are found in people with depression, and the associated poor sleep 
quality, and altered circadian rhythms, increase resistance to insulin action and hence the risk of type 2 diabetes 
development (Courtet, 2012, Gangwisch, 2009). Furthermore, chronic inflammation and increased C-reactive 
protein, TNF-α and pro-inflammatory cytokines, are noted in patients with diabetes and has been implicated in 
causing depression in humans (Dantzer 2008, Musselman, 2003). Finally, several environmental factors, such as 
childhood adversity and poverty increase predisposition to both depression and diabetes (de Vet, 2011). 
 
4. RELATIONSHIP BETWEEN DIABETES CONTROL, DIABETIC 
COMPLICATIONS AND DEPRESSION 
Depression may impair glycemic control through its negative effects on diabetes self-care behaviors, 
such as, adherence to diet, exercise and medications and the regularly checking of their blood glucose. 
On the other hand, patients’ complications resulting from diabetes, such as nephropathy requiring 
hemodialysis, or retinopathy and blindness, or neuropathy, often lead to significant impairment in the 
daily lives of patients with diabetes and this by itself may increase their risk of developing depression. 
A meta-analysis, including 24 studies, was conducted, and showed that there was a relationship between 
depression and poor glycemic control among patients with diabetes (Lustman, 2000).  Another study 
tried  to investigate the association between major depression and the glycemic control among patients 
with type 2 diabetes mellitus, and showed that those patients who displayed depression, had a 
significantly higher levels of glycosylated hemoglobin (8.6 ± 2.0), versus those who did not exhibit a 
mood disorder (7.5 ± 1.8) (Papelbaum, 2011). Similarly, the longitudinal effect of depression on 
glycemic control was investigated, in a sample of patients, with type 2 diabetes, and showed that 
unadjusted HbA1c means were significantly higher among patients who were depressed, when 
compared to those who were non-depressed, at all time points during the study follow-up up till 3 years 
of follow-up (Abuhegazy, 2016). Similarly several cross-sectional studies conducted in patients with 
type I diabetes showed that there is a significant association between glycosylated hemoglobin and 
depressive symptoms (Van Tilburg, 2007, Lustman, 2007, de Groot, 2001). As for the association 
between diabetic complications and depression, a meta-analysis of 27 studies showed a significant 
association between depression and diabetes micro-vascular complications, such as neuropathy, 
retinopathy, nephropathy, and  macro-vascular complications, such as cardiovascular and 
cerebrovascular disease and sexual dysfunction as well (Pouwer, 2010). However the sample size of the 
individual studies included in the meta-analyses were small. A prospective study conducted showed 
that major depression was associated with increased risk of developing microvascular and 
macrovascular complications over a period of 5 years, and this was present even after adjusting for 
diabetes severity and self-care activities (Lin, 2010). Furthermore, the majority of reports confirm the 
presence of the relationship between diabetic neuropathy and depression (Veglio, 1993). A cross-
sectional study also found that there is a relationship between diabetic nephropathy stage and likelihood 
or severity of depression in patients with diabetes, and showed that in patients with diabetes, progression 
of nephropathy is associated with increased risk of developing depression and with increased severity 
of depression (Takasaki 2016). In addition, a literature review done showed that depression is even 
common in patients with diabetic retinopathy and this had a negative effect on the condition of 
retinopathy (Chen, 2016). Regardless of the influences that depression and diabetes exert on each other, 
it is clear that patients with these comorbid disorders do incur higher healthcare costs than non-
depressed patients with diabetes (Ciechanowski, 2000). 
 
 
 
 
 
 
5. CLINICAL COURSE OF DEPRESSION IN DIABETES 
 The course of depression in diabetes was found to be persistent and/or recurrent even after successful initial 
treatment.  Persistence or recurrence of depression was identified in 23 out of 25 patients (92% of participants), 
with an average of 4.8 depressive episodes over 5-years follow-up period, and even after the successful initial 
treatment of depression, recurrence was very common, occurring in 80% of the patients (Lustman, 1997).  A 
randomized controlled trial involving 164 patients with diabetes assigned to collaborative care intervention versus 
165 patients with diabetes assigned to usual care, and followed up to a 1 year, showed that depressive symptoms, 
which was assessed through the use of Hopkins Symptoms Checklist 90 (SCL-90), persisted in around 60 % of 
intervention group compared to 68 % of the group who received usual care (Katon 2004). Therefore, patients with 
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diabetes and history of depressive episode are at high risk of having a relapse, especially when they are faced with 
stressor, being health-related or psychosocial. 
 
6. TREATMENT OF DEPRESSION IN DIABETES     
There are three broad categories to treat depression in diabetes and these include diabetes self-management 
education, psychotherapy and pharmacotherapy. A meta-analyses was conducted including 14 RCTs of patients 
with diabetes and depression,  6 studies utilized pharmacotherapy, 5 utilized psychotherapy, 3 studies combined  
psychotherapy and a moderate (-0.512) overall effect size was identified which was large (-0.581) for 
psychotherapeutic interventions combined with educational interventions concerning diabetes self-care and 
moderate (-0.467) for pharmacological interventions (van der Feltz-Cornelis 2010). Psychotherapy or 
pharmacological therapy combined with psychoeducation and psychosocial interventions yield beneficial results, 
and diabetes management and glycemic control is of importance as well (Simon, 2007, van der Feltz-Cornelis 
2010). 
 
7. CONCLUSIONS   
a- Depression is highly prevalent, persistent and recurrent in patients with diabetes. The link 
between depression and diabetes is better understood nowadays.  
b- Patients with higher glycosylated hemoglobin or having complications of diabetes are more 
likely to have associated depression and worse quality of life. American Diabetes Association currently 
recommends that patients with DM, especially those with poor glycemic control, should be screened 
for depression.                     
  c- Concerning management of patients with diabetes and depression psychotherapy or 
pharmacological treatment combined with psychoeducation and psychosocial interventions seem to be 
cost-effective. 
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